Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United Sts Brent Oil Fd Lp Unit
BNO
US Stock MarketDetailed Quotes
Lexicon Pharmaceuticals (LXRX)
- 2.300
- +0.120+5.50%
Close Aug 21 16:00 ET
1.02BMarket Cap-14.38P/E (TTM)
2.310High2.190Low3.19MVolume2.190Open2.180Prev Close7.30MTurnover1.46%Turnover RatioLossP/E (Static)444.96MShares2.68052wk High5.87P/B503.67MFloat Cap1.03052wk Low--Dividend TTM218.99MShs Float344.750Historical High--Div Yield TTM5.51%Range %0.284Historical Low2.284Avg Price1Lot Size
Lexicon Pharmaceuticals (LXRX) Key Financial Indicators
LXRX Earnings per Share (EPS)
According to the latest financial report of Lexicon Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.07. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
LXRX Free Cash Flow (FCF)
Interested in knowing about Lexicon Pharmaceuticals's free cash flow? The latest report shows it as -9.19M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
LXRX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lexicon Pharmaceuticals shows that the company's current ratio is 13.37, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
LXRX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lexicon Pharmaceuticals, the quick ratio is 13.07, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
LXRX Return on Equity (ROE)
Want to learn more about the financial health of Lexicon Pharmaceuticals? The latest ROE figure is -16.84%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
LXRX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lexicon Pharmaceuticals, the total asset return on investment (ROA) is -12.25%.
Currency: USD
Quarterly
Loading...
LXRX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lexicon Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 94.36%.
Currency: USD
Quarterly
Loading...
LXRX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lexicon Pharmaceuticals, the net profit margin is -4.59K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm